Security key
68062P106
Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA)
CUSIP: 68062P106
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 91,696,172
- Total 13F shares
- 58,658,581
- Share change
- +913,984
- Total reported value
- $700,332,942
- Put/Call ratio
- 16%
- Price per share
- $11.94
- Number of holders
- 129
- Value change
- +$12,555,131
- Number of buys
- 65
- Number of sells
- 58
Report period
Q3 2024
Institutions
129
Top holders
10
OLMA full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Olema Pharmaceuticals, Inc. SEC filings
Olema Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68062P106
Recent filing periods:
Top shareholders of OLMA - Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
10%
|
9,135,893
|
$98,850,362 | — | 30 Jun 2024 | |
| Paradigm Biocapital Advisors LP |
3/4/5
13F
|
10%+ Owner · Company |
8.6%
from 13F
|
13,407,200
|
$173,767,954 | — | 01 Aug 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
4.4%
|
4,000,000
|
$43,280,000 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.4%
|
3,999,518
|
$43,274,785 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
3.5%
|
3,211,927
|
$34,753,047 | — | 30 Jun 2024 | |
| Logos Global Management LP |
13F
|
Company |
3.5%
|
3,208,875
|
$34,720,028 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
2,742,664
|
$29,675,624 | — | 30 Jun 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
2.9%
|
2,654,867
|
$28,725,661 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
1,947,977
|
$21,077,111 | — | 30 Jun 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
2%
|
1,873,704
|
$20,273,477 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.8%
|
1,684,924
|
$18,232,886 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,060,099
|
$11,472,974 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
1.2%
|
1,058,673
|
$11,454,307 | — | 30 Jun 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.1%
|
1,000,000
|
$10,820,000 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.99%
|
905,257
|
$9,794,881 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.93%
|
852,554
|
$9,224,634 | — | 30 Jun 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.87%
|
796,880
|
$8,622,242 | — | 30 Jun 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.84%
|
774,792
|
$8,383,250 | — | 30 Jun 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
0.71%
|
650,000
|
$7,033,000 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.64%
|
588,996
|
$6,372,937 | — | 30 Jun 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.6%
|
550,000
|
$5,951,000 | — | 30 Jun 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.6%
|
546,863
|
$5,917,058 | — | 30 Jun 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.48%
|
441,066
|
$4,772,333 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.44%
|
401,105
|
$4,339,956 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.38%
|
344,082
|
$3,722,967 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.37%
|
335,571
|
$3,630,878 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.35%
|
325,000
|
$3,516,500 | — | 30 Jun 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.3%
|
275,000
|
$2,975,500 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.28%
|
253,874
|
$2,746,916 | — | 30 Jun 2024 | |
| HighVista Strategies LLC |
13F
|
Company |
0.27%
|
247,880
|
$2,682,062 | — | 30 Jun 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.24%
|
216,500
|
$2,342,530 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.23%
|
208,583
|
$2,256,868 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.2%
|
182,120
|
$1,970,538 | — | 30 Jun 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.17%
|
159,739
|
$1,728,376 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.17%
|
158,625
|
$1,716,323 | — | 30 Jun 2024 | |
| Newtyn Management, LLC |
13F
|
Company |
0.15%
|
140,000
|
$1,514,800 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
139,923
|
$1,513,967 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.15%
|
133,395
|
$1,443,334 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.14%
|
132,253
|
$1,430,977 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.14%
|
129,500
|
$1,401,190 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.13%
|
123,196
|
$1,332,981 | — | 30 Jun 2024 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.13%
|
118,480
|
$1,281,954 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.13%
|
118,434
|
$1,281,455 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.13%
|
116,926
|
$1,265,139 | — | 30 Jun 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.13%
|
114,642
|
$1,240,426 | — | 30 Jun 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.11%
|
102,006
|
$1,103,705 | — | 30 Jun 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.1%
|
87,397
|
$945,636 | — | 30 Jun 2024 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.1%
|
87,312
|
$944,716 | — | 30 Jun 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.09%
|
83,590
|
$904,444 | — | 30 Jun 2024 | |
| Dana Investment Advisors, Inc. |
13F
|
Company |
0.08%
|
74,657
|
$807,789 | — | 30 Jun 2024 |
Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA) as of Q3 2024
As of 30 Sep 2024,
Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,658,581 shares.
The largest 10 holders included
BVF INC/IL, Paradigm Biocapital Advisors LP, Deep Track Capital, LP, BlackRock, Inc., Point72 Asset Management, L.P., Logos Global Management LP, MPM BIOIMPACT LLC, VANGUARD GROUP INC, STATE STREET CORP, and Pictet Asset Management Holding SA.
This page lists
129
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
127
Q3 2024 holders
129
Holder diff
2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.